Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
03
06
2021
accepted:
03
09
2021
revised:
01
10
2021
pubmed:
22
9
2021
medline:
15
12
2021
entrez:
21
9
2021
Statut:
epublish
Résumé
Research is urgently needed to reduce the morbidity and mortality of Lassa fever (LF), including clinical trials to test new therapies and to verify the efficacy and safety of the only current treatment recommendation, ribavirin, which has a weak clinical evidence base. To help establish a basis for the development of an adaptable, standardised clinical trial methodology, we conducted a systematic review to identify the clinical characteristics and outcomes of LF and describe how LF has historically been defined and assessed in the scientific literature. Primary clinical studies and reports of patients with suspected and confirmed diagnosis of LF published in the peer-reviewed literature before 15 April 2021 were included. Publications were selected following a two-stage screening of abstracts, then full-texts, by two independent reviewers at each stage. Data were extracted, verified, and summarised using descriptive statistics. 147 publications were included, primarily case reports (36%), case series (28%), and cohort studies (20%); only 2 quasi-randomised studies (1%) were found. Data are mostly from Nigeria (52% of individuals, 41% of publications) and Sierra Leone (42% of individuals, 31% of publications). The results corroborate the World Health Organisation characterisation of LF presentation. However, a broader spectrum of presenting symptoms is evident, such as gastrointestinal illness and other nervous system and musculoskeletal disorders that are not commonly included as indicators of LF. The overall case fatality ratio was 30% in laboratory-confirmed cases (1896/6373 reported in 109 publications). Systematic review is an important tool in the clinical characterisation of diseases with limited publications. The results herein provide a more complete understanding of the spectrum of disease which is relevant to clinical trial design. This review demonstrates the need for coordination across the LF research community to generate harmonised research methods that can contribute to building a strong evidence base for new treatments and foster confidence in their integration into clinical care.
Sections du résumé
BACKGROUND
Research is urgently needed to reduce the morbidity and mortality of Lassa fever (LF), including clinical trials to test new therapies and to verify the efficacy and safety of the only current treatment recommendation, ribavirin, which has a weak clinical evidence base. To help establish a basis for the development of an adaptable, standardised clinical trial methodology, we conducted a systematic review to identify the clinical characteristics and outcomes of LF and describe how LF has historically been defined and assessed in the scientific literature.
METHODOLOGY
Primary clinical studies and reports of patients with suspected and confirmed diagnosis of LF published in the peer-reviewed literature before 15 April 2021 were included. Publications were selected following a two-stage screening of abstracts, then full-texts, by two independent reviewers at each stage. Data were extracted, verified, and summarised using descriptive statistics.
RESULTS
147 publications were included, primarily case reports (36%), case series (28%), and cohort studies (20%); only 2 quasi-randomised studies (1%) were found. Data are mostly from Nigeria (52% of individuals, 41% of publications) and Sierra Leone (42% of individuals, 31% of publications). The results corroborate the World Health Organisation characterisation of LF presentation. However, a broader spectrum of presenting symptoms is evident, such as gastrointestinal illness and other nervous system and musculoskeletal disorders that are not commonly included as indicators of LF. The overall case fatality ratio was 30% in laboratory-confirmed cases (1896/6373 reported in 109 publications).
CONCLUSION
Systematic review is an important tool in the clinical characterisation of diseases with limited publications. The results herein provide a more complete understanding of the spectrum of disease which is relevant to clinical trial design. This review demonstrates the need for coordination across the LF research community to generate harmonised research methods that can contribute to building a strong evidence base for new treatments and foster confidence in their integration into clinical care.
Identifiants
pubmed: 34547033
doi: 10.1371/journal.pntd.0009788
pii: PNTD-D-21-00823
pmc: PMC8486098
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0009788Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Viruses. 2020 Sep 23;12(10):
pubmed: 32977629
Trans R Soc Trop Med Hyg. 2020 May 7;114(5):385-396
pubmed: 32125412
J Trop Med Hyg. 1992 Jun;95(3):197-201
pubmed: 1597876
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Harefuah. 1988 Jan 1;114(1):12-4
pubmed: 3350404
Sci Rep. 2018 Apr 12;8(1):5939
pubmed: 29651117
Case Rep Neurol Med. 2016;2016:1978461
pubmed: 27957363
Midwives Chron. 1985 May;1168(98):136-8
pubmed: 3846752
Bull World Health Organ. 1977;55(4):435-9
pubmed: 304386
Br Med J (Clin Res Ed). 1982 Oct 9;285(6347):1001-2
pubmed: 6812716
PLoS Negl Trop Dis. 2021 Mar 8;15(3):e0009169
pubmed: 33684118
Emerg Infect Dis. 2006 May;12(5):835-7
pubmed: 16704848
Int J Infect Dis. 2013 Nov;17(11):e1011-6
pubmed: 23871405
PLoS Negl Trop Dis. 2017 Jul 3;11(7):e0005711
pubmed: 28671959
Microorganisms. 2021 Apr 07;9(4):
pubmed: 33917071
BMJ Glob Health. 2019 Feb 7;4(Suppl 2):e001116
pubmed: 30899575
Br Med J. 1973 Sep 22;3(5881):616-7
pubmed: 4755184
Afr Health Sci. 2014 Dec;14(4):1074-7
pubmed: 25834520
Bull World Health Organ. 1975;52(4-6):599-604
pubmed: 1085214
Vector Borne Zoonotic Dis. 2001 Winter;1(4):269-81
pubmed: 12653127
BMC Public Health. 2020 Feb 12;20(1):217
pubmed: 32050926
Int J Infect Dis. 2019 Dec;89:84-86
pubmed: 31465848
Virol J. 2011 Jun 20;8:314
pubmed: 21689444
N Engl J Med. 1977 Oct 13;297(15):803-7
pubmed: 895819
Int J Infect Dis. 2020 Mar;92:49-52
pubmed: 31866549
Am J Pathol. 1982 Jun;107(3):349-56
pubmed: 7081389
BMC Infect Dis. 2019 Jul 10;19(1):606
pubmed: 31291900
Open Forum Infect Dis. 2016 Sep 20;3(4):ofw198
pubmed: 27975074
Br Med J (Clin Res Ed). 1983 Jul 2;287(6384):48
pubmed: 6407689
Emerg Infect Dis. 2019 Sep;25(9):1753-1756
pubmed: 31441759
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004834
pubmed: 19370612
BMJ. 1988 Sep 3;297(6648):584-7
pubmed: 3139220
Antiviral Res. 1992 Aug;19(2):139-47
pubmed: 1444324
Br Med J. 1977 May 28;1(6073):1399-402
pubmed: 861652
Emerg Infect Dis. 2010 Oct;16(10):1598-600
pubmed: 20875288
Am J Trop Med Hyg. 1973 Nov;22(6):780-4
pubmed: 4745237
Virol J. 2011 Aug 15;8:404
pubmed: 21843352
Lancet. 1985 Nov 30;2(8466):1227-9
pubmed: 2866301
Med Klin (Munich). 2000 Jun 15;95(6):340-5
pubmed: 10935419
Trop Med Int Health. 2015 Nov;20(11):1424-1430
pubmed: 26171669
Am J Trop Med Hyg. 2018 Oct;99(4):1062-1065
pubmed: 30062993
Ghana Med J. 2012 Sep;46(3):166-70
pubmed: 23661832
J Cardiol. 1989 Dec;19(4):1147-56
pubmed: 2486633
PLoS Negl Trop Dis. 2021 Sep 21;15(9):e0009788
pubmed: 34547033
Mil Med Res. 2020 Feb 29;7(1):7
pubmed: 32111253
PLoS Negl Trop Dis. 2018 Mar 29;12(3):e0006361
pubmed: 29596412
J Nucl Med. 1983 Aug;24(8):750-1
pubmed: 6875688
J Virol. 2000 Aug;74(15):6992-7004
pubmed: 10888638
Can Dis Wkly Rep. 1989 Sep 30;15(39):193-8
pubmed: 2590947
BMC Infect Dis. 2019 Jul 19;19(1):647
pubmed: 31324229
Future Sci OA. 2020 Aug 13;6(10):FSO620
pubmed: 33312698
Euro Surveill. 2017 Sep;22(39):
pubmed: 29019307
Am J Trop Med Hyg. 2015 Jan;92(1):172-7
pubmed: 25404077
Aviat Space Environ Med. 2012 May;83(5):527-30
pubmed: 22606871
J Infect. 2020 Jun;80(6):671-693
pubmed: 32027872
Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S783-9
pubmed: 2749109
J Int Med Res. 2020 Jan;48(1):300060518821552
pubmed: 30657006
Trans R Soc Trop Med Hyg. 1984;78(3):319-24
pubmed: 6464130
J Trop Med Hyg. 1978 Jul;81(7):134-6
pubmed: 702621
Lancet Glob Health. 2021 Apr;9(4):e469-e478
pubmed: 33740408
Am J Trop Med Hyg. 1970 Jul;19(4):677-9
pubmed: 4987546
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD005067
pubmed: 18843677
Oncotarget. 2016 May 10;7(19):27910-5
pubmed: 27058894
Front Public Health. 2018 Aug 29;6:232
pubmed: 30211144
Trans R Soc Trop Med Hyg. 1972;66(3):390-401
pubmed: 5046379
Pan Afr Med J. 2012;11:55
pubmed: 22593791
J Clin Microbiol. 2010 Jun;48(6):2009-13
pubmed: 20351210
Am J Trop Med Hyg. 2018 Nov;99(5):1110-1111
pubmed: 30404683
Lancet. 1984 Oct 20;2(8408):926
pubmed: 6148643
Arch Pathol. 1975 Nov;99(11):599-604
pubmed: 1227472
Am J Trop Med Hyg. 1974 Nov;23(6):1140-9
pubmed: 4429183
Am J Trop Med Hyg. 1970 Jul;19(4):695-6
pubmed: 4987549
Epidemiol Rev. 2019 Jan 31;41(1):28-33
pubmed: 31673694
Emerg Infect Dis. 2020 Dec;26(12):3091-3093
pubmed: 33219806
BMC Infect Dis. 2021 Feb 4;21(1):143
pubmed: 33541278
Br J Haematol. 1989 Aug;72(4):543-8
pubmed: 2775659
J Infect Dis. 2017 Jun 15;215(12):1862-1872
pubmed: 28863472
Virol J. 2011 Oct 24;8:478
pubmed: 22023795
BMC Med. 2020 Jun 25;18(1):190
pubmed: 32586391
J Infect. 2020 May;80(5):578-606
pubmed: 31926184
Lancet. 1980 Sep 20;2(8195 pt 1):649-50
pubmed: 6107442
Lancet Infect Dis. 2018 Jun;18(6):684-695
pubmed: 29523497
Trans R Soc Trop Med Hyg. 1988;82(2):311
pubmed: 3188161
Int J Infect Dis. 2020 Nov;100:82-87
pubmed: 32795603
J Infect Dis. 1987 Mar;155(3):456-64
pubmed: 3805773
Nurs Times. 1986 Sep 17-23;82(38):72-81
pubmed: 3640375
Am J Trop Med Hyg. 1986 Mar;35(2):401-7
pubmed: 3953952
J Med Virol. 1988 Oct;26(2):127-35
pubmed: 3183637
Infect Dis Poverty. 2020 Aug 10;9(1):110
pubmed: 32778167
JAMA. 1990 Oct 24-31;264(16):2093-6
pubmed: 2214077
J Virus Erad. 2018 Oct 01;4(4):225-227
pubmed: 30515301
Postgrad Med J. 1991 Feb;67(784):193-4
pubmed: 2041853
Tropenmed Parasitol. 1980 Dec;31(4):389-98
pubmed: 7233535
BMC Infect Dis. 2019 Jul 11;19(1):610
pubmed: 31296177
BMJ. 1995 Sep 30;311(7009):857-9
pubmed: 7580496
J Clin Microbiol. 2000 Jul;38(7):2670-7
pubmed: 10878062
Int J Infect Dis. 2021 Feb;103:124-131
pubmed: 33176203
PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2748
pubmed: 24651047
J Infect Dis. 1988 Oct;158(4):872-5
pubmed: 3171229
Emerg Infect Dis. 2019 Jun;25(6):1066-1074
pubmed: 31107222
J Trop Med Hyg. 1989 Oct;92(5):350-5
pubmed: 2810453
Am J Trop Med Hyg. 2013 Feb;88(2):241-4
pubmed: 23390223
Crit Rev Clin Lab Sci. 2004;41(4):339-90
pubmed: 15487592
Ned Tijdschr Geneeskd. 2002 Nov 16;146(46):2201-4
pubmed: 12467165
Emerg Infect Dis. 2019 Aug;25(8):
pubmed: 31310586
Open Forum Infect Dis. 2018 Jul 16;5(7):ofy131
pubmed: 30035149
Clin Infect Dis. 2017 Sep 1;65(5):855-859
pubmed: 29017278
PLoS Negl Trop Dis. 2020 Aug 26;14(8):e0008589
pubmed: 32845889
Trop Med Int Health. 2012 Aug;17(8):1001-4
pubmed: 22594713
Clin Infect Dis. 2017 Feb 15;64(4):501-509
pubmed: 28172588
Ann Emerg Med. 2005 Mar;45(3):323-6
pubmed: 15726058
Int J Infect Dis. 2019 Oct;87:15-20
pubmed: 31357056
Case Rep Obstet Gynecol. 2016;2016:9673683
pubmed: 27051545
J Infect Dis. 2001 Aug 1;184(3):345-9
pubmed: 11443561
Ned Tijdschr Geneeskd. 1982 Mar 27;126(13):566-9
pubmed: 7200196
J Pediatric Infect Dis Soc. 2019 Dec 27;8(6):519-524
pubmed: 30272215
Euro Surveill. 2009 Feb 12;14(6):
pubmed: 19215723
J Virol. 2019 Oct 15;93(21):
pubmed: 31413134
Trans R Soc Trop Med Hyg. 1972;66(3):381-9
pubmed: 5046378
Niger J Clin Pract. 2014 Sep-Oct;17(5):658-61
pubmed: 25244282
PLoS One. 2020 Dec 10;15(12):e0243766
pubmed: 33301526
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Euro Surveill. 2020 Apr;25(15):
pubmed: 32317052
Int J Infect Dis. 2010 Sep;14 Suppl 3:e333-4
pubmed: 20579914
N Engl J Med. 2018 Nov 1;379(18):1745-1753
pubmed: 30332564
Am J Trop Med Hyg. 1987 Mar;36(2):408-15
pubmed: 3826501
PLoS Negl Trop Dis. 2015 May 21;9(5):e0003793
pubmed: 25996783
Lancet. 1989 Nov 18;2(8673):1222
pubmed: 2572935
Lancet Infect Dis. 2010 Nov;10(11):803-12
pubmed: 20822958
J Public Health Afr. 2021 Feb 24;11(2):1323
pubmed: 33680412
PLoS Negl Trop Dis. 2013;7(3):e2130
pubmed: 23556016
Bull Soc Pathol Exot Filiales. 1972 Sep-Oct;65(5):642-50
pubmed: 4679205
Afr J Lab Med. 2019 Aug 22;8(1):803
pubmed: 31534915
Trans R Soc Trop Med Hyg. 1986;80(4):577-82
pubmed: 3810792
J Hosp Infect. 2003 Nov;55(3):234-5
pubmed: 14572492
Am J Trop Med Hyg. 2022 Jun 27;107(4):856-862
pubmed: 35895416
J Infect Dis. 1987 Mar;155(3):445-55
pubmed: 3805772
Trop Med Int Health. 2001 Jan;6(1):83-4
pubmed: 11251899
PLoS Negl Trop Dis. 2022 Jan 6;16(1):e0010089
pubmed: 34990453
J Med Case Rep. 2009 Jan 29;3:36
pubmed: 19178735
Case Rep Infect Dis. 2017;2017:8242313
pubmed: 29391958
Am J Trop Med Hyg. 2020 Nov 23;104(2):585-592
pubmed: 33241780
Virol J. 2013 Apr 19;10:123
pubmed: 23597024
J Infect. 1982 Jan;4(1):73-7
pubmed: 7185979
Am J Trop Med Hyg. 1973 Nov;22(6):773-9
pubmed: 4745236
Trans R Soc Trop Med Hyg. 1984;78(4):549-53
pubmed: 6485062
Emerg Infect Dis. 2020 Nov;26(11):2625-2637
pubmed: 33079033
PLoS Negl Trop Dis. 2012;6(9):e1839
pubmed: 23029594
Case Rep Neurol. 2018 Jul 3;10(2):150-158
pubmed: 30057542
BMC Infect Dis. 2015 May 29;15:217
pubmed: 26022703
PLoS Negl Trop Dis. 2018 Nov 30;12(11):e0006971
pubmed: 30500827
Am J Trop Med Hyg. 1970 Jul;19(4):670-6
pubmed: 4246571
Microbes Infect. 2002 Jan;4(1):43-50
pubmed: 11825774
Trans R Soc Trop Med Hyg. 2010 Jan;104(1):51-4
pubmed: 19712954
Eur Arch Otorhinolaryngol. 2011 Feb;268(2):197-201
pubmed: 20809263
MMWR Morb Mortal Wkly Rep. 2004 Oct 1;53(38):894-7
pubmed: 15457145
Trans R Soc Trop Med Hyg. 2014 Mar;108(3):126-32
pubmed: 24535150
Can J Public Health. 1976 Sep-Oct;67(5):361-6, 369-74
pubmed: 991041
Br Med J. 1976 Nov 13;2(6045):1173
pubmed: 791445
N Engl J Med. 1986 Jan 2;314(1):20-6
pubmed: 3940312
N Engl J Med. 1990 Oct 18;323(16):1120-3
pubmed: 2215580
Afr J Lab Med. 2016 Apr 25;5(1):288
pubmed: 28879105
Am J Public Health. 2018 Feb;108(2):262-264
pubmed: 29267063
Int J Infect Dis. 2019 Jun;83:88-94
pubmed: 30930184
BMC Infect Dis. 2018 Dec 17;18(1):667
pubmed: 30558538